You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Screen for hepatitis B virus in all cancer patients starting systemic treatment. Find out more about hepatitis B virus screening and management.

Drug Formulary
About the Drug Formulary Email Drug Formulary Team
Regimen
Published Date: 12 Aug 2025
Cancer Type:
Central Nervous System
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation and Monitoring sections

Aug 2025
Regimen
Published Date: 12 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 12 Aug 2025
Cancer Type:
Breast, 
Gynecologic, 
Endometrial
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Regimen
Published Date: 12 Aug 2025
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Adjuvant
Revision Summary:

Regimen Monograph: Updated Pregnancy/Lactation section

Aug 2025
Drug

Published Date: 12 Aug 2025

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Aug 2025
Drug

Published Date: 12 Aug 2025

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation section
Aug 2025
Drug

Published Date: 12 Aug 2025

Revision Summary:
Drug Monograph: Updated Pregnancy/Lactation and Monitoring sections
Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Premedication and Supportive Measures section, added link to T-Cell Engaging Antibody Guideline.

Aug 2025
Regimen
Published Date: 07 Aug 2025
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Funding information, Premedication and Supportive Measures, Dose Modifications, Drug Administration and Special Precautions, and Recommended Clinical Monitoring sections, added links to T-Cell Engaging Antibody Guideline

Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Hematologic, 
Leukemia - Chronic Lymphocytic (CLL)
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Revision Summary:

Regimen Monograph: Updated Rationale/Uses and Supplementary Public Funding sections

Aug 2025
Regimen
Published Date: 01 Aug 2025
Cancer Type:
Genitourinary, 
Prostate
Show More Show more tags
, Show Less Show fewer tags
Intent: Curative, Palliative
Revision Summary:

Regimen Monograph: Updated Intent, Rationale/Uses, Supplementary Public Funding, Drug Regimen, Cycle Frequency, and Administration sections

Aug 2025

Pages